Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by puffdragon699on Apr 13, 2017 8:22pm
269 Views
Post# 26121286

RE:RE:RE:RE:What can justify the share price now?

RE:RE:RE:RE:What can justify the share price now?
Monteviale wrote: I always back up my posts with current information.  It may have been me as I was posting a month ago and if it was, I will stand by what I posted a month ago.  My logic has been consistent through all my posts and I stand by all my earlier posts.  

To be fair to the person that asked the question, you should really back out $4 million in earnings reported in today's net income as it didn't come from their growing operations but from strategic investments.

I'm have always been very bullish on Aphria, but I also question management on a daily basis.  I take nothing for granted.  

Tell me, why do you think Aphria chose today to release their quarterly report without giving shareholders advanced notice?  Are they trying to bury something in today's report?  Why the increase in CGS?  How do they project an increase in yield from 70 grams per square foot to 75 grams per square foot when yield actually decreased in their last quarter?  

Yes, there are a lot of unanswered questions, but I'm still bullish on Aphria and believe they are the clear industry leader.  However, I will continue to question all their moves and if they stumble or dont execute their business plan, I wont have any trouble selling my shares.  I dont think they will stumble, but if there is one thing I am sure of it is still too early in the game to determine who the winner will be.  A lot can change in three years and people should only be in love with a stock so long as a company is performing to expectations.   Always be aware of whats going on and don't be afraid to question managements decsion.  




Thanks for the great discussion here. Very refreshing not to be accused of being a basher by asking the "tough" but legit questions.

I agree with brent re.the time-line....much to happen,especially after legalization happens.During that time,all the other  40plus medical MJ producers will be doing everything to ramp up expansion and production capacity and many,many more new players will come along adding to capacity and future supply.As in the US ,where states  have legalized MJ,I also expect a significant drop in product . 

https://www.thecannabist.co/2017/01/18/marijuana-price-drops-state-revenue/71657/
Bullboard Posts